Dr. Koch is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1800 Mulberry St
Scranton, PA 18510Phone+1 570-703-8000Fax+1 570-703-8002
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1979 - 1982
The MetroHealth System/Case Western Reserve UniversityResidency, Internal Medicine, 1976 - 1979
Case Western Reserve University School of MedicineClass of 1976
Certifications & Licensure
FL State Medical License 1982 - 2025
GU State Medical License Active through 2025
NC State Medical License 2000 - 2024
PA State Medical License 2015 - 2024
HI State Medical License 2018 - 2022
MA State Medical License 2017 - 2022
NM State Medical License 2015 - 2018- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Publications & Presentations
PubMed
- 37 citationsReversibility of liver damage in rats rendered resistant to carbon tetrachloride by prior carbon tetrachloride administration: Bearing on the lipoperoxidation hypothesisGiancarlo Ugazio, Robert R. Koch, Richard O. Recknagel
Experimental and Molecular Pathology. 1973-06-01 - 57 citationsMechanism of protection against carbon tetrachloride by prior carbon tetrachloride administration.Giancarlo Ugazio, Robert R. Koch, Richard O. Recknagel
Experimental and Molecular Pathology. 1972-06-01 - 59 citationsHepatotoxicity of bromotrichloromethane— bond dissociation energy and lipoperoxidation☆Robert R. Koch, Eric A. Glende, Richard O. Recknagel
Biochemical Pharmacology. 1974-10-15
Press Mentions
Raymond L. Erikson, PhD: In Memoriam (1936–2020)June 5th, 2020- The EMT Transcription Factor ZEB2 Promotes Proliferation of Primary and Metastatic Melanoma While Suppressing an Invasive, Mesenchymal-like PhenotypeMay 18th, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
